In older adults with atrial fibrillation or heart failure, which statement about digoxin is correct?

Study for the AGS Beers Criteria Test. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam with comprehensive resources!

Multiple Choice

In older adults with atrial fibrillation or heart failure, which statement about digoxin is correct?

Explanation:
Digoxin has a very narrow therapeutic window and older adults often have reduced kidney function and multiple medications, which raise the risk of toxicity. For atrial fibrillation, digoxin can help slow the heart rate, but it isn’t the first-line choice since other drugs (like beta-blockers or certain calcium channel blockers) are typically preferred for rate control. For heart failure, digoxin may relieve symptoms and reduce hospitalizations, but it does not reduce mortality, so it isn’t a first-line life-extending therapy. Because of these risks, if digoxin is used in older adults, keeping the dose at or below 0.125 mg per day is advised to minimize toxicity. Some patients with very reduced renal function may require even lower dosing and close monitoring of kidney function and electrolytes. This is why the statement about avoiding higher doses aligns with safer, guideline-consistent practice.

Digoxin has a very narrow therapeutic window and older adults often have reduced kidney function and multiple medications, which raise the risk of toxicity. For atrial fibrillation, digoxin can help slow the heart rate, but it isn’t the first-line choice since other drugs (like beta-blockers or certain calcium channel blockers) are typically preferred for rate control. For heart failure, digoxin may relieve symptoms and reduce hospitalizations, but it does not reduce mortality, so it isn’t a first-line life-extending therapy. Because of these risks, if digoxin is used in older adults, keeping the dose at or below 0.125 mg per day is advised to minimize toxicity. Some patients with very reduced renal function may require even lower dosing and close monitoring of kidney function and electrolytes. This is why the statement about avoiding higher doses aligns with safer, guideline-consistent practice.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy